WHO ICTRP trial
Effect of Sumac in treatment of polycystic ovary syndrome
IRCT20120415009472N21 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20120415009472N21 |
|---|---|
| Public title | Effect of Sumac in treatment of polycystic ovary syndrome |
| Scientific title | Effect of Sumac powder on Antioxidant indices and Uric Acid in women with polycystic ovary syndrome |
| Primary sponsor | Iran University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of) |
| Conditions | Polycystic ovary syndrome. E28.2;Poly cysti |
| Interventions | Intervention 1: Control group: Patients referring to Akbar Abadi Hospital who are willing to cooperate and have inclusion criteria will recieve starch. They will use 3 gram Starch from Golha factory ( 3 capsules of 1 gram) for 3 months… |
| Registration date | Jan 6, 2020 |
| Target size | 88 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: